chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shingles outbreak on right flank, pain and blisters lasted 5 days after starting valtrex
Information has been received from a physician concerning a 4 year old female patient who was vaccinated with a dose of MMR II at 16 months of age. Antibody titers were drawn "recently" and the mumps titer was "low." The measles and rubella titers were adequate. The exact antibody titer results were not provided. The patient sought medical attention at the physician's office. No product quality complaint was involved. Additional information has been requested.
Patient developed tearing of the right eye on 2/24/21 followed by progressive right side facial weakness that resulted in an ED visit on 2/27/21.
Vaccine received after recommended by perinatal specialist on 8/11/2021 at the Pharmacy, Normal ultrasound 8/12/2021 8/19/2021 patient developed nausea/vomiting/diarrhea 8/24/2021 patient presents with severe abdominal pain running from hips to center of abdomen and down legs. She is seen and discharged.  Patient then presents to the facility and diagnosed with small abruption at 22 weeks. On 8/26 she spontaneously delivers at 22 weeks. Infant was peri-viable and intubation was attempted but ultimately did not survive
Pt given PNEUMOVAX 23 and PREVNAR 13 at same visit by accident. Documented and reported in case of adverse reaction.
Information has been received from a 67 years old female patient referring to herself. Concomitant medication included other unspecified medications. The patient had none medical history, drug reactions or allergies. In December 2017, the patient received her first dose with PNEUMOVAX 23 (reported as PNEUMOVAX) (strength, dose, lot# and expiration date were not reported) intramuscularly for prophylaxis with no adverse effect. On 17-DEC-2018, the patient received her 2nd dose of PNEUMOVAX 23 (strength, dose, lot# and expiration date were not reported) intramuscularly for prophylaxis. On 18-DEC-2018 (reported as the day after vaccination with her second dose of PNEUMOVAX 23, the patient experienced redness, pain, and swelling beginning about an inch below the injection site down the bicep area towards her elbow. On an unknown date in December 2018, the patient was itching in the bicep area. The patient spoke with physician for medical attention. The patient treated the symptoms with ice and by taking ibuprofen, which helped to alleviate the symptoms. There was no lab diagnostics/studies performed. At the time of reported, the only thing that still lingers was itching and occasional soreness in that bicep area which she was still experiencing. Causality assessment was not provided.
Initial report received from other company (Merck) on 04 December 2012. This case was initially reported by a healthcare professional. Other company reference number: 1-5748203747. A patient, whose age, gender, medical history and concomitant medications were not reported, had received a dose of FLUZONE vaccine (lot number, dose number, route and site of vaccination were not reported) on an unspecified date. It was reported that on an unspecified date, after vaccination, the patient developed a swollen tongue and throat. Laboratory data was not reported. The patient did not receive any corrective treatment. On an unspecified date, the events resolved without treatment. List of documents held by sender: none.
I started with a dry cough which was unusual. I was tired, but more so than usual. I tested myself around 06:00PM and it came back positive, over the course of the evening my chest got heavy like I was getting a cold. I was very sleepy. I did a screening that night online and was able to get the Paxlovid prescription, which I picked up the next morning. I have had a sore throat on and off, but the fatigue and coughing are the main issues. I feel all little better, I am home from work today. I have not had a fever and I have had sweats and chills a little bit.
Following routine volleyball practice, patient developed heartburn, lightheadedness, and palpitations.  Elevated heart rate noted by this reporter (mom and also RN), called Peds on-call and were directed to ED.  Patient was found to be in SVT with heart rate over 250.  After several tries, able to reduce HR to 110-120 range with vagal maneuvers, discharged home to follow-up with pediatric cardiology (patient has no medical history).  Correlation unknown and long-term effects yet unknown (currently wearing long-term heart monitor with other testing and follow-up pending).
CONFIRMED CLINICAL VACCINE FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a male of unspecified age, race and ethnic origin. Initial information was processed along with additional information received from the department on 19-APR-2023. The patient's weight, height, and medical history were not reported. The patient was previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1808609 expiry: UNKNOWN) dose was not reported, 1 total administered on 23-MAR-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1822811 expiry: UNKNOWN) dose was not reported, 1 total administered on 29-OCT-2021 for covid-19 prophylaxis. No concomitant medications were reported. On 09-SEP-2022, the patient had positive strike on Binex test, the patient experienced sickness for 5 days which was confirmed covid-19 infection, and confirmed clinical vaccine failure (dose number in series 2). The patient reported that, the patient's immunity weaned since patient did not had a COVID vaccine in 2 years. On an unspecified date in SEP-2022, treatment medications included: nirmatrelvir/ritonavir (Paxlovid) for covid-19 infection. On an unspecified date, in SEP-2022, Laboratory data included: SARS-CoV-2 test results showed negative next 2 weeks but QuickVue test showed negative (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from confirmed covid-19 infection on 14-SEP-2022, and the outcome of confirmed clinical vaccine failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000279481 and 90000279482. The suspected product quality complaint has been confirmed to be voided for 90000279481 (as the reported illness is relevant to efficacy post administration of the booster and no pqc identified for the primary vaccination) based on the PQC evaluation/investigation performed.; Sender's Comments: V0: 20230438449-confirmed clinical vaccine failure. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.
This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 293493). A 55-year-old female patient received an intramuscular injection of FLUZONE 2007-2008 (lot number U2488AA). Approximately five hours after vaccination, the patient presented to the emergency department with a dry cough and red eyes. It was noted that the patient may have been experiencing an allergic reaction, and she was prescribed hydrocodone cough syrup and TAMIFLU (which she did not fill). The patient later experienced wheezing, cough, flu symptoms, and a racing heart. The events subsequently recovered.
Red wheel with swelling and heat (about 3-4 inch diameter). Soreness.
Case number PHEH2014US025327, is an initial spontaneous report from a medical assistant received on 16 Dec 2014. This report refers to a 65-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient had tolerated vaccines (no further details provided) well in the past. On 28 Oct 2014, the patient was vaccinated with 0.5 ml of FLUVIRIN (batch number: 145701, expiry date: Mar 2015) intramuscularly into left deltoid muscle that was stored at minus 0.6 degrees Celsius for 2 hours and 50 minutes. No adverse reaction was reported following this medication error.
got the vaccines too, have shingles/suspected vaccination failure; shingles; Worst pain; burning skin like on fire; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and burning sensation skin. On an unknown date, the outcome of the vaccination failure, pain and burning sensation skin were unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain and burning sensation skin to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 15-AUG-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received Shingles vaccines too and was experiencing shingles. The patient also experienced worst pain and burning skin liked on fire. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary immunization, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
I have a lots of pain in my hand where I received the vaccination; It is too painful; This is a spontaneous report from a contactable consumer (patient, self-reporting). A patient of unspecified age and gender received unspecified dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), unknown dose via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. Medical history included allergic to preservatives (patient cannot take preservatives). The patient concomitant medications were not reported. The patient experienced had lots of pain in hand where received the vaccination; it is too painful. The outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This spontaneous report as received from a physician via company representative a 12 year old male patient. The patient's medical history was not reported. Approximately in April 2014 (Reported as in the past week) the patient was vaccinated with GARDASIL (Dose number 1). Concomitant medications were not reported. Approximately in April 2014 (reported as in the past week) the physician stated that after the patient received the GARDASIL he was tired and lethargic but coherent. When the patient "got to the car he fell asleep immediately. The physician brought the patient back into the office and had the patient stay there for an hour. The patient was given some sugar to alleviate any glycemic issues but it was not believed to be a problem with the patient's glycemic levels. No further information provided. The outcome was reported as recovered/resolved. The causality was not reported. Additional information is not expected.
This spontaneous report as received from a licensed practical nurse refers to multiple patients of unknown age and gender. There was no information about the patients' pertinent medical histories, concomitant medications and drug reactions or allergies provided. On multiple unspecified dates, the patients were vaccinated with an improperly stored doses of GARDASIL 9 (lot# L000610 with expiration date 31-JAN-2017, dose, anatomical location and route of administration were not reported). It was also reported that the first improperly stored doses were administered on 15-JUL-2015. The reporting nurse stated that the products were exposed to a low temperature of 33 Fahrenheit for an unknown amount of time. On an unknown dates, there were multiple excursions for these product encompassing various lot numbers (some of which were exhausted). No adverse effects were reported. This is one of several reported received from the same reporter. Additional information is not expected as there was no consent for follow up.
Severe blood clots in heart, lungs and both legs. Had horrible pain January and by February 23, 2022 went to ER and found after a CT scan I had a huge blood clots in my heart and lungs, later ultrasound found many more clots in both my legs
Pt recv vax & several hr later devel fever 102.Soreness at inj site & headache. Pt tx w/Tylenol & recovered. This is 1 of 3 family members to exp adverse exp after Typhoid vax.
felt tired/achy; felt tired/achy all day; didn't spike a fever until Friday night.; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (felt tired/achy), FATIGUE (felt tired/achy all day) and PYREXIA (didn't spike a fever until Friday night.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2022, the patient experienced PAIN (felt tired/achy), FATIGUE (felt tired/achy all day) and PYREXIA (didn't spike a fever until Friday night.). At the time of the report, PAIN (felt tired/achy), FATIGUE (felt tired/achy all day) and PYREXIA (didn't spike a fever until Friday night.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The patient received their Moderna booster on Thursday and felt tired/achy all day Friday but didn't spike a fever until Friday night. The patient was trying to determine if that was still a result.  No treatment information was provided.
got tested for COVID; shortness of breath; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), DYSPNOEA (shortness of breath), FATIGUE (fatigue) and COVID-19 (got tested for COVID) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concomitant products included Heart medicine, CHOLESTEROL and OTC vitamins for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced NAUSEA (nausea). On 01-Feb-2021, the patient experienced DYSPNOEA (shortness of breath) and FATIGUE (fatigue). On 02-Feb-2021, the patient experienced COVID-19 (got tested for COVID). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Jan-2021, NAUSEA (nausea) had resolved. At the time of the report, DYSPNOEA (shortness of breath), FATIGUE (fatigue) and COVID-19 (got tested for COVID) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Treatment details included Tylenol.
This spontaneous report as received from a healthcare worker (certified medical assistant) refers to a patient of unknown age. On 16-APR-2014 the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date unspecified), subcutaneous that was improperly exposed to 8F for 8 hours. No known adverse effects. Additional information has been requested.
This spontaneous report was received from an approximately 67 year old female nurse practitioner, who is also the patient, with severe arthritis since 1999 and KEFLEX drug allergy, regarding herself. On an unknown date in summer 2006, the patient was vaccinated with a dose of ZOSTAVAX (route, lot number and expiration date were not provided). Concomitant therapies included XARELTO. On an unknown date in 2007, the patient was diagnosed with chronic lymphocytic leukemia (CLL), she also experienced that same year, blood clots that were determined to be related to CLL. On an unspecified date in November 2011, the patient underwent a knee replacement due to her severe arthritis. On 30-JAN-2015, the patient experienced neck pain. Subsequently on 03-FEB-2015, the reporter developed a red rash on her neck that, on the next day, became blistered and extended from the back of her neck to her shoulder and down the midline to her chest. It was reported that the patient did not seek for medical attention, no treatment was given for the events. Nor labs diagnostics studies were performed. The outcome of the events was reported as not recovered. Upon internal assessment the events of chronic lymphocytic leukemia was considered to be medically significant. Additional information has been requested.
Shortly after that I began to bleed lightly from my uterus; Once receiving the vaccination, a couple hrs later my uterus felt odd maybe even light burning at one point.; Once receiving the vaccination, a couple hrs later my uterus felt odd maybe even light burning at one point.; I had mild headache as well.; This is a spontaneous report received from a contactable consumer (Patient). A 26-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm on 06May2021 19:00 (Batch/Lot Number: EW0171) as 1st dose, single for covid-19 immunization. Patient had no medical history, no allergies to medications. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. On 07May2021 at 02:00, once received the vaccination, a couple hours later her uterus felt odd maybe even light burning at one point. Shortly after that she began to bleed lightly from her uterus. This was 8 days after her last period. Vaccine triggered the bleeding outside of her cycle. she bleeds from her uterus lightly for almost a week. she had mild headache as well. No treatment were received. The outcome for events was unknown.
I had pain in my arm which got worse into Friday night and into Saturday; Had a pain in a tiny spot, in a muscle /The pain, I couldn't even lift my leg for that muscle.; The pain I couldn't even lift my leg for that muscle; pain in my arm increased; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 77-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 29Sep2023 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 77 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose1; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose2; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose3; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose4; unknown manufacturer), for COVID-19 immunization. The following information was reported: MYALGIA (non-serious) with onset 29Sep2023, outcome "not recovered", described as "Had a pain in a tiny spot, in a muscle /The pain, I couldn't even lift my leg for that muscle."; PAIN IN EXTREMITY (non-serious) with onset 29Sep2023, outcome "not recovered", described as "I had pain in my arm which got worse into Friday night and into Saturday"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 29Sep2023, outcome "not recovered", described as "The pain I couldn't even lift my leg for that muscle"; PAIN (non-serious) with onset 29Sep2023, outcome "not recovered", described as "pain in my arm increased". The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Moderna COVID-19 Vaccine EUA  I have a golf ball size supraclavicular lymph node above the left clavicle bone, which has grown larger over the course of the last few days.
Patient did not experience any adverse symptoms from the IPOL vaccine.  Reporting because vaccine was administered past the expiration date. Expired on 10/3/2021 but administered on 10/15/2021.  Data review of vaccination reports in March 2022 is how the administration of the expired vaccine was noticed.   As directed by CDC guidelines and Sanofi Pasteur, patient was asked to return to office for an additional dose.
Fainting/possible seizure episode after receiving MCV4 #2. Patient was lightheaded with muscle stiffening and eyes rolled back after receiving MCV4 #2. With vaccines, no hx of seizures. Patient has not eaten today. Patient/client feels lightheaded. Stiffness in chair and slides down in chair. Assisted to floor and cool compress to head and neck by LVN. Call to 911. Pt has no hx of seizures, no hx of diabetes. Has not eaten today. Patient awake and breathing, laying on floor. 10:05am Fire Dept and EMS responded. BP: 110/80, HR-60, Resp-14. SPO2-95%. Blood glucose 106. RN 7/11/16 10:11am Patient feels lightheaded after blood glucose checked. Patient accepts EMS services to take ambulance to hospital. RN Additional note: Patient was given apple juice just before EMS arrived. RN
Pt received initial covid19 vaccine (pfizer) on 2/2/21 without any issues, than on 3/2/21 received 2nd vaccine and on 3/12/21 he reportedly fell at home. Was brought to  ER on 3/16/2021 with dizziness and weakness along with unable to get words out at the time and had to crawl towards doorway prior to being brought to ER.  Pt was dx as TIA, CKD stage 3, HTN, Iron deficiency anemia
Cellulitis at site s/p injection. Seen 2/15 advised BENADRYL worsened. Rechecked 2-18. Area: 15cm x 7cm, tender. Treated with BACTRIM DS.
10:00 94 yo female c/o N/V while she was sitting in a chair at  post vaccination observation area. Pt's Son took the patient to ladies room, Patient vomited x1. c/o diszziness.  Onsite paramedic responded and transferred the patient in a strecher to the EMS observation area. 10: 10 peripheral pulse weak P 84, BP 100/70, R20 ( with supine postion), The patient refused to be transferred   to ER. family member( son) wanted to transfer the patient to ER. 10:20 peripheral pulse: weak. P 82, BP 107/70, R 20( supine postion) 1050 peripheral pulse :weak, P 84, BP 105/75, R20 ( supine postion) 11: 00 P41,BP105/60, R 40 Patient agreed to transfer to ER. 11:15  Called 911 to transfer the patient
In mid Feb, I felt tinnitus and ringing in my right ear. At night the ringing would get louder. I began to experience what felt like a nervous shock that would start at my head and travel down to my chest. It would either wake me up or happen as I wake up. I visited my Dr. who rx'd Gabapentin and Ativan which helped me sleep through the night.
Significant shivering/chills (approx 12 hours), sore arm with redness (aprox 2 in diameter)